For the three months ended December 31, 2024, Arcturus reported a net loss of approximately $30.0 million, or ($1.11) per diluted share, compared with a net loss of $11.7 million, or ($0.44 ...
With its unique mRNA therapeutics platform, Arcturus Therapeutics is a leading ... or to produce therapeutic proteins of interest. Compared to other non-self-replicating mRNA-based therapeutic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback